Clinical Scorecard: Microbiome Analysis of the Penis in Histologically Confirmed Lichen Sclerosus: A Comparative Examination of Urethral and Preputial Samples
At a Glance
Category
Detail
Condition
Penile Lichen Sclerosus (PLS)
Key Mechanisms
Chronic fibrotic inflammation potentially driven by immune dysregulation, chronic irritation, infection, urinary micro-incontinence, and genetic factors affecting extracellular matrix proteins
Target Population
Uncircumcised males, especially those with phimosis
Care Setting
Urology and dermatology outpatient and surgical settings
Key Highlights
PLS predominantly affects uncircumcised males and is strongly associated with phimosis.
Microbiome differences exist between uncircumcised and circumcised males, with higher prevalence of pathogenic bacteria in uncircumcised men.
Diagnosis relies on lesion morphology and history; biopsy is indicated for uncertain or refractory cases.
Guideline-Based Recommendations
Diagnosis
Clinical assessment based on lesion morphology and patient history.
Biopsy recommended when diagnosis is uncertain or treatment-resistant.
Avoid unnecessary urethral swabs and systemic antibiotics to prevent disruption of physiological flora.
Management
Circumcision is indicated for phimosis and confirmed lichen sclerosus.
Avoid systemic antibiotics unless clearly indicated to preserve microbiome integrity.
Monitoring & Follow-up
Monitor for progression to phimosis or urethral strictures.
Assess for potential malignant transformation due to chronic inflammation.
Risks
Chronic inflammation increases risk of penile cancer.
Use of systemic antibiotics may disrupt normal penile and systemic microbiota.
Patient & Prescribing Data
Uncircumcised males with phimosis or suspected penile lichen sclerosus
Systemic antibiotics are often prescribed empirically but may disrupt normal flora; biopsy-guided diagnosis supports targeted management.
Clinical Best Practices
Perform standardized preputial and urethral swabs prior to circumcision without prior disinfection to accurately assess microbiome.
Exclude patients with recent antibiotic, antifungal, or corticosteroid use to avoid confounding microbiome analysis.
Use molecular diagnostics to detect HPV and other sexually transmitted pathogens in relevant cases.
Consider immune dysregulation and genetic factors in pathogenesis when planning management.
